Buerger’s Disease Stem Cell Treatment in Delhi, India

Buerger’s disease, medically known as thromboangiitis obliterans, is a rare condition in which small and medium blood vessels in the arms and legs become inflamed and blocked by blood clots. Reduced blood flow can cause severe pain, non-healing ulcers, and in advanced cases, tissue death and gangrene.

The condition is almost exclusively seen in people who smoke or use tobacco in other forms, and its progression is closely tied to continued tobacco use. Standard management focuses on complete cessation of smoking, pain control and, in severe cases, surgical intervention. Stem cell therapy is being explored as a way to support new blood vessel formation and improve circulation to affected limbs, working alongside — not in place of — smoking cessation.

• Pain in the hands, feet, arms or legs, often worse with activity
• Open sores or ulcers on fingers or toes
• Inflamed, tender veins
• Pale or bluish skin on fingers or toes, particularly in cold conditions

Buerger’s disease is generally understood to progress through three phases:

Acute Phase: Active vessel inflammation causes sudden pain, tenderness and warmth in the affected area, often the first noticeable sign of the condition.

Subacute Phase: Inflammation eases somewhat, but clots persist and blood flow remains restricted, with ongoing discomfort, discolouration and coldness in the hands or feet.

Chronic Phase: Long-term vessel scarring and narrowing lead to poor perfusion, skin ulcers or gangrene, and, in severe cases, a risk of amputation.

• Cigarette smoking or tobacco chewing, present in nearly all diagnosed cases
• Tobacco-related inflammation and thickening of blood vessel walls
• Increased blood clotting tendency linked to tobacco use
• A possible autoimmune component in some patients
• Genetic predisposition
• Cold climate, which can worsen circulation-related symptoms
• Chronic stress as a minor contributing factor

Progression to Critical Limb Ischemia

In advanced cases, Buerger’s disease can progress to critical limb ischemia, where blood supply to the hand or leg drops sharply. Patients may experience intense pain even at rest, discoloured or blackened skin at the extremities, and slow-healing wounds that can progress to ulcers or gangrene if tobacco use continues.

There is no single definitive test for Buerger’s disease; diagnosis relies on ruling out other conditions and assessing characteristic signs and symptoms. Common diagnostic tools include:

Blood tests: Help rule out autoimmune diseases such as lupus or scleroderma, clotting disorders, and diabetes.

Allen’s Test: A simple bedside test assessing blood flow through the arteries of the hand.

Angiography: Imaging of the arteries, sometimes with contrast dye, to visualise blockages; both symptomatic and asymptomatic limbs are often examined since the disease can affect more than one limb.

Complete cessation of tobacco use is the cornerstone of managing Buerger’s disease; without it, disease progression is very difficult to control. Medications may help manage pain and improve circulation, and in severe cases with poor prognosis for tobacco cessation, other treatments including stem cell-based approaches are being studied as an option aimed at supporting new vessel growth, improving local circulation, and aiding ulcer healing.

Treatment typically begins with a medical evaluation of circulation and pain severity, followed by collection of the patient’s own stem cells from bone marrow or adipose tissue, laboratory processing and concentration of the cells, and administration to the affected areas to support new vessel formation, tissue repair and reduced inflammation. Follow-up monitoring tracks the body’s response over subsequent months.

Typical Treatment Timeline

Day 1: Airport pickup, doctor consultation, admission formalities, clinical examination and lab work, and supportive therapy.

Day 2: The stem cell procedure, supportive therapies and physiotherapy.

Day 3: Further supportive therapy and physiotherapy, discharge, and airport drop-off.

Patients are asked to bring identification documents and hard copies of medical reports.

Delivery methods include intravenous infusion, intramuscular injection into affected limb muscles, intra-arterial delivery for faster reach to blocked vessels, subcutaneous injection near damaged tissue, and surgical administration in more advanced cases.

• Improved circulation supporting reduced pain during activity or rest
• Better walking distance without discomfort
• Faster wound healing where circulation improves
• Reduced reliance on pain medication over time
• Potential reduction in amputation risk with improved blood flow

Stem cell therapy for Buerger’s Disease is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Buerger’s Disease, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Buerger’s Disease isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Buerger’s Disease are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Buerger’s Disease continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

Stem Cell Care India states that it evaluates each patient individually before starting treatment, uses advanced laboratory processes, provides ongoing communication and education about hygiene and safety throughout treatment, and aims to offer emotional support alongside medical care.

Cost varies with disease severity, the number of stem cell administrations required, the type of cells used, pre-treatment tests, length of hospital stay, and any additional therapies recommended after treatment. A free consultation is recommended before committing to a treatment plan.

Reported success depends heavily on disease severity, continued abstinence from tobacco, patient age, stem cell quality, and adherence to post-treatment care. Continued smoking after treatment is described as significantly impairing recovery and undermining any benefit from the therapy.

• May stimulate new blood vessel formation in affected areas
• Can support reduced pain, numbness and cramping
• May help reduce vascular inflammation
• In some cases associated with reduced amputation risk

The clinic describes patient screening prior to treatment, hygienic and controlled stem cell harvesting, laboratory testing of cells, sterilisation and temperature monitoring during processing, a final quality assessment before implantation, and post-treatment monitoring of healing progress.

Reported outcomes at the clinic include improved blood flow, reduced leg and toe pain, faster healing of non-healing ulcers, less numbness and tingling, easier walking, reduced inflammation, and better sleep due to less nighttime pain. Patients who stop smoking and maintain a healthy lifestyle are described as having the best chance of benefiting from treatment.

Thabo M. (Botswana): Reports significant leg and hand pain from Buerger’s disease that limited walking and sleep, with improved circulation and no more burning sensation after several months of treatment.

Azlan R. (Malaysia): Describes years without relief from medication, followed by healed ulcers, reduced numbness and more energy after stem cell treatment at the clinic.

Julien D. (France): Reports worsening leg pain and cold fingers before treatment, with noticeably better circulation and pain-free standing within a few weeks of therapy.

Mehmet K. (Turkey): Describes severe walking pain before treatment and reduced leg swelling with easier daily activity afterward.

Carlos V. (Chile): Reports long-term pain and unhealed ulcers before treatment, with improved blood flow and reduced pain within a couple of months of therapy.

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Buerger’s Disease, and a supporting team of medical staff is described as being available throughout the process.

Follow-up is provided through call and video consultations, review of health check-up reports, and guidance on diet, medication, exercise and smoking cessation, which the clinic states are essential to sustained recovery.

• Occupational therapy to ease daily tasks affected by pain and reduced circulation
• Sensory integration techniques for numbness or burning sensations
• Nutritional guidance emphasising foods that support circulation and healing
• Psychological support to manage the stress associated with chronic pain
• Hyperbaric oxygen therapy to support wound healing in some cases

International patients cite treatment cost, experienced vascular specialists, modern medical technology, individualised treatment planning and shorter waiting times as reasons for pursuing Buerger’s disease-related stem cell therapy in India.

Buerger’s disease is a serious, tobacco-linked vascular condition that can threaten limb viability if not managed early and consistently.

Complete cessation of tobacco use remains the single most important step a patient can take, regardless of which other treatments are pursued.

Stem cell therapy is being explored as a supportive option aimed at improving circulation and aiding tissue healing, but it should be considered investigational and discussed thoroughly with a vascular specialist before proceeding.